Antal Rohit Desai sold $4.7M of PRCT
director at PROCEPT BioRobotics Corp. 75,000 shares at an average of $62.93, traded Jun 10, 2025, filed Jun 12, 2025.
Score components
- +15RoleDirector
- +25Trade size$4.7M at market
- +20Share of holdings soldSold 84% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -7.4%, 3m -36.8%, 6m -41.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-25-031117, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 10, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -4,862 | $63.23 | $307k | 84,501 | Jun 12, 2025 |
| Jun 10, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -18,412 | $64.02 | $1.2M | 66,089 | Jun 12, 2025 |
| Jun 10, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -1,726 | $64.67 | $112k | 64,363 | Jun 12, 2025 |
| Jun 10, 2025 | AGrant or award Common Stock10b5-1 | +1,538 | $0.00 | $0 | 8,403 | Jun 12, 2025 |
| Jun 11, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -7,788 | $62.59 | $487k | 56,575 | Jun 12, 2025 |
| Jun 11, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -11,495 | $63.47 | $730k | 45,080 | Jun 12, 2025 |
| Jun 11, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -5,717 | $64.27 | $367k | 39,363 | Jun 12, 2025 |
| Jun 12, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -19,951 | $61.28 | $1.2M | 19,412 | Jun 12, 2025 |
| Jun 12, 2025 | SOpen-market sale Common Stockindirect: By The 2:22 DNA Trust10b5-1 | -5,049 | $62.33 | $315k | 14,363 | Jun 12, 2025 |
| Jun 10, 2025 | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +2,771 | $0.00 | $0 | 2,771 | Jun 12, 2025 |
Related signals
Other insiders at PROCEPT BioRobotics Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $6,223 297 shares | -0% | |
| 30Weak | PROCEPT BioRobotics Corp | Barry L Templin EVP, Chief Technology Officer | $7,815 373 shares | -0% | |
| 37Weak | PROCEPT BioRobotics Corp | Kevin Waters EVP, CFO | $7,815 373 shares | -0% | |
| 59Moderate | PRCTbuy PROCEPT BioRobotics Corp | Larry L Wood President, CEO | $498k 23,900 shares | - | |
| 30Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $8,117 285 shares | -0% | |
| 30Weak | PROCEPT BioRobotics Corp | Barry L Templin EVP, Chief Technology Officer | $10k 358 shares | -1% | |
| 37Weak | PROCEPT BioRobotics Corp | Kevin Waters EVP, CFO | $10k 357 shares | -0% | |
| 23Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $8,559 304 shares | -0% | |
| 14Weak | PROCEPT BioRobotics Corp | Alaleh Nouri EVP, CLO, CORP. SEC. | $139k 5,363 shares | -5% | |
| 30Weak | PROCEPT BioRobotics Corp | Kevin Waters EVP, CFO | $20k 706 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.